China FDA Releases Guidance on Acceptance of Foreign Medical Device Study Data

by Ropes & Gray LLP

Ropes & Gray LLP

On January 10, 2018, the China Food and Drug Administration (“CFDA”) announced the implementation of the Technical Guidelines Governing Acceptance of Medical Device Clinical Data from Foreign Studies (the “2017 Guidelines”). The long-awaited 2017 Guidelines explain the principles, acceptance criteria, technical requirements and considerations for accepting foreign study data in support of marketing submissions for medical devices. More importantly, the 2017 Guidelines provide a promising prospect for device manufacturers to avoid or reduce duplicating clinical studies in China and to accelerate their device approval timelines in China. Device manufacturers are advised to carefully review the 2017 Guidelines and analyze the implications on their device registrations in China.

The CFDA has acknowledged the concept of referencing foreign study data in device approvals since 2015, i.e., the Technical Guidelines Governing Medical Device Clinical Evaluation (the “2015 Clinical Guidelines”).1 Compared with the 2015 Clinical Guidelines, the 2017 Guidelines (i) provide acceptance criteria and considerations for the acceptance of foreign study data, and (ii) expand the eligible products to cover in-vitro diagnostic reagents and high-risk devices listed in the List of Class III Devices Subject to Clinical Trial Approval.2

According to the 2017 Guidelines, any foreign study data submitted to the CFDA must meet with three basic principles: (i) the foreign study must follow the ethic rules stipulated by the Declaration of Helsinki; (ii) the foreign study must be conducted in accordance with good clinical practices, and the device applicant and clinical site must accept CFDA’s inspections; and (iii) the foreign study data must be authentic, scientific, reliable and traceable, and the device applicant has to provide complete study data, not selected data.

Typical foreign study data materials generally include the ethics committee opinions, the clinical study protocol, and the clinical study report. Pursuant to the 2017 Guidelines, the CFDA will accept foreign study data, provided that (i) such data can meet the regulatory requirements in China, and (ii) such data is scientific, complete and sufficient. If the CFDA finds any foreign study data inadequate under applicable technical requirements, the device applicant may need to conduct a supplementary study in or outside China.

In addition, the 2017 Guidelines specify three special considerations that the CFDA may consider in its technical review process concerning whether, and to what extent, foreign study data can support the marketing approval of a device application, including (i) differences in regulatory requirements; (ii) differences in study populations; and (iii) differences in clinical conditions. Where such differences may have clinical significance, the device applicant will likely need to conduct a supplementary in-country study.

1See our previous analysis for the 2015 Clinical Guideline. 
2On August 25, 2014, the CFDA promulgated the List of Class III Devices Subject to Clinical Trial Approvals (No.14 [2014] CFDA Notice), effective as of October 1, 2014.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ropes & Gray LLP | Attorney Advertising

Written by:

Ropes & Gray LLP

Ropes & Gray LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.